- Home
- ATXS vs TRTX Comparison
ATXS vs TRTX Comparison
Compare ATXS & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- TRTX
- Stock Information
- Founded
- ATXS 2008
- TRTX 2014
- Country
- ATXS United States
- TRTX United States
- Employees
- ATXS N/A
- TRTX N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- TRTX Real Estate Investment Trusts
- Sector
- ATXS Health Care
- TRTX Real Estate
- Exchange
- ATXS Nasdaq
- TRTX Nasdaq
- Market Cap
- ATXS 676.1M
- TRTX 708.3M
- IPO Year
- ATXS 2015
- TRTX 2017
- Fundamental
- Price
- ATXS $12.50
- TRTX $8.80
- Analyst Decision
- ATXS Hold
- TRTX Buy
- Analyst Count
- ATXS 6
- TRTX 3
- Target Price
- ATXS $24.33
- TRTX $10.75
- AVG Volume (30 Days)
- ATXS 936.9K
- TRTX 557.6K
- Earning Date
- ATXS 11-12-2025
- TRTX 10-28-2025
- Dividend Yield
- ATXS N/A
- TRTX 10.96%
- EPS Growth
- ATXS N/A
- TRTX N/A
- EPS
- ATXS N/A
- TRTX 0.65
- Revenue
- ATXS $706,000.00
- TRTX $138,590,000.00
- Revenue This Year
- ATXS N/A
- TRTX N/A
- Revenue Next Year
- ATXS N/A
- TRTX $6.62
- P/E Ratio
- ATXS N/A
- TRTX $13.60
- Revenue Growth
- ATXS N/A
- TRTX 4.13
- 52 Week Low
- ATXS $3.56
- TRTX $6.47
- 52 Week High
- ATXS $12.72
- TRTX $9.85
- Technical
- Relative Strength Index (RSI)
- ATXS 67.29
- TRTX 46.36
- Support Level
- ATXS $12.31
- TRTX $8.68
- Resistance Level
- ATXS $12.62
- TRTX $8.89
- Average True Range (ATR)
- ATXS 0.23
- TRTX 0.16
- MACD
- ATXS -0.17
- TRTX -0.02
- Stochastic Oscillator
- ATXS 72.73
- TRTX 25.85
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.